Subgroup Analyses in RRMM Patients Receiving Real-Life Standard of Care in the LocoMMotion Study International Myeloma Foundation 4:36 2 years ago 128 Далее Скачать
Key findings of the LocoMMotion study VJHemOnc – Video Journal of Hematology & HemOnc 1:41 2 years ago 50 Далее Скачать
Isatuximab plus carfilzomib and dex in patients with RRMM: IKEMA subgroup analysis International Myeloma Foundation 7:55 3 years ago 186 Далее Скачать
LOCOMMOTION: analysis of SOC for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:17 3 years ago 61 Далее Скачать
KarMMa-3 subgroup analysis: ide-cel vs standard regimens in triple-class exposed myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:55 1 year ago 152 Далее Скачать
Subgroup analyses of CASTOR & POLLUX in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:50 2 years ago 39 Далее Скачать
HORIZON subgroup analyses: melfufen and dexamethasone in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 6:19 4 years ago 59 Далее Скачать
EPCORE NHL-1 subgroup analyses: epcoritamab monotherapy in patients with R/R LBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:46 2 years ago 238 Далее Скачать
HORIZON study: EMD subgroup analysis VJHemOnc – Video Journal of Hematology & HemOnc 4:05 4 years ago 31 Далее Скачать
IMAGE subgroup analysis: real-world experience of Isa-Pd in patients with R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:15 1 year ago 155 Далее Скачать
Dr. Chari on the Subgroup Analysis of MMY1001 in Multiple Myeloma OncLive 1:31 6 years ago 240 Далее Скачать
MAJESTIC-1 Study -A Subgroup Analysis of High-risk Patients | Luciano Costa, MD | EHA2024 HealthTree Foundation for Multiple Myeloma 2:29 6 months ago 112 Далее Скачать
Updates from ICARIA-MM, a phase 3 study of Isa + pomalidomide & low-dose dex (Pd) versus Pd in RRMM International Myeloma Foundation 7:11 3 years ago 352 Далее Скачать
Subgroup analysis of the DETERMINATION trial: RVD vs. autoSCT in patients with multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:42 2 years ago 133 Далее Скачать
CARTITUDE-4 Subgroup Analysis of Functional High-Risk Patients | Luciano Costa, MD | EHA 2024 HealthTree Foundation for Multiple Myeloma 3:44 6 months ago 270 Далее Скачать
IKEMA subgroup analysis: Isa + Kd in patients who previously underwent transplantation VJHemOnc – Video Journal of Hematology & HemOnc 3:51 3 years ago 61 Далее Скачать
MASTER subgroup analysis: quadruplet induction, autoSCT & treatment cessation in NDMM patients ≥70 VJHemOnc – Video Journal of Hematology & HemOnc 1:34 1 year ago 31 Далее Скачать
Impact of Chromosome 1 Abnormalities Among Pts with NDMM: Subgroup Analysis from the ENDURANCE Trial International Myeloma Foundation 7:58 3 years ago 570 Далее Скачать
Subgroup analyses in the HORIZON trial of melflufen plus dexamethasone in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:27 3 years ago 49 Далее Скачать
